articles about mycoplasma

When 1+1 is more than 2: interactions causing the Porcine respiratory disease complex (PRDC) (2/3)
In this second instalment, Cano and Segalés talk about tools for detecting PRDC on farms, the factors influencing its development, and vaccination.

When 1+1 is more than 2: interactions causing the Porcine respiratory disease complex (PRDC) (1/3)
Jean Paul Cano, a veterinarian with extensive field experience in US and now in Spain, provided practical field insights into managing PRDC in production settings. Joaquim Segalés, UAB professor and CReSA researcher, offered an academic perspective and share the latest findings on PRDC pathogenesis.

Ceva Swine Innovation Summit 2025: Advancing Swine Health Through Science and Partnership
The first Ceva Swine Innovation Summit brought together more than 200 swine health experts from over 20 countries.

Evolution of lung lesions in recent years: What information can we learn from this?
Assessing lung lesions at slaughter is useful for monitoring their evolution over time, and thus estimating the effectiveness of the measures implemented to control these diseases.

Health restart: the power of depopulation and repopulation to restore profitability
When losses and costs from poor health threaten the current and future farm profitability, perhaps a “clean slate” should be considered.

MSD Animal Health Unveils Swine Protect & Connect™, A Unique Herd Management Ecosystem Uniting Swine Health, Technology, and Individual Pig Care
Swine Protect & Connect™ advances precision swine health management by integrating intradermal vaccination (PORCILIS®), needle-free delivery (IDAL™), and animal-level traceability (LeeO) to help maximise swine production.

Allen D. Leman Swine Conference 2024 Summary: Health
The last of the three summaries by Antonio Palomo dedicated to the 2024 edition of the Allen D. Leman Conference focuses on health: biosecurity and viral and bacterial diseases.

Description of a Mycoplasma hyopneumoniae aerosol infection model in pigs
Aerosol models may open a new range of possibilities for addressing knowledge gaps concerning M. hyopneumoniae infection and disease, treatment, and control.
A diagnostic approach to confirm Mycoplasma hyopneumoniae “Day zero” for pathogen eradication

Ceva receives EU marketing authorization granted by the EU Commission for Cirbloc® M Hyo, a new Ready To Use vaccine to protect pigs against PCV2 and Mycoplasma hyopneumoniae
The new vaccine is based on the PCV2d genotype, the most circulating one in the field and on the Mycoplasma hyopneumoniae (M. hyo) strain BA 2940.

Summary of the 27th IPVS and 15th ESPHM-ECPHM: sanitation, immunology, vaccines
In this second installment, Antonio Palomo summarizes the papers and posters on health, immunology, and vaccines presented at the latest edition of the IPVS and ESPHM-ECPHM in Leipzig.

55th AASV Annual Meeting summary: Health
Antonio Palomo summarizes the presentations on swine health from the recent edition of the AASV that took place in Nashville (Tennessee).

Productive and economic impact of pig lung lesions detected at slaughter
Detection of lung lesions in slaughtered pigs also allows estimation of economic losses.
Dysbiosis of gut microbiota and intestinal barrier dysfunction in pigs with pulmonary inflammation induced by Mycoplasma hyorhinis infection

The impact of discontinuing perinatal antibiotic treatments in piglets
Side effects of perinatal medications on the microbiota can be detrimental to animal health.